Mologen AG announce the appointment of Dr. Alfredo Zurlo as member of the executive board and Chief Medical Officer. As of April 1, 2013 Dr. Zurlo, a board-certified oncologist with strong expertise in the pharma industry, will shape the company's clinical development programs, provide strategic input, and supervise all current and upcoming clinical trials of MOLOGEN. He has 13 years of extensive experience in clinical drug development, medical strategy, clinical trial design for both pre and post approval studies and in regulatory affairs.